King Ryan A sold $11.4M of CHYM (indirect holdings)

King Ryan A (Co-Founder) sold 375,000 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $30.27 ($29.00–$31.10, $11.35M total) across 3 trades on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · King Ryan A
Published Aug 10, 2026, 11:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 11:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Neutral
medium confidence
Mentioned
$CHYM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity, but the filing alone does not change CHYM fundamentals or provide new guidance.

02

Market read

A large CHYM insider sale ($11.35M) is disclosed, but the 10b5-1 pre-arrangement suggests limited incremental information about near-term business outlook.

03

What to watch

The sale is described as indirect holdings; without details on the indirect structure, the market may over-interpret the signal.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-10 for trades dated 2026-08-06

Background

The article is an SEC Form 4 insider transaction disclosure for Chime Financial, Inc. (CHYM) by co-founder King Ryan A, executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$CHYMNeutralMedium confidence
Context

Chime Financial co-founder King Ryan A sold $11.35M of CHYM via an open-market sale under a pre-arranged 10b5-1 plan, leaving 0 shares.

Expected impact

Likely limited near-term impact; any effect is more about signaling than fundamentals given the 10b5-1 structure.

Evidence & confidence

Form 4 discloses transaction size ($11.35M) and timing (2026-08-06) but does not provide new operating or guidance information. 10b5-1 plans typically reduce interpretive weight versus discretionary sales.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Chime Financial, Inc.

    Subject of the Form 4 insider transaction disclosure (CHYM).

  • King Ryan A

    Co-founder, officer/director, sold CHYM shares via open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.